表紙
市場調査レポート

MediPoint:脊椎固定-現在/将来の主要企業

MediPoint: Spinal Fusion - Current and Future Players

発行 GlobalData 商品コード 306664
出版日 ページ情報 英文 79 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
MediPoint:脊椎固定-現在/将来の主要企業 MediPoint: Spinal Fusion - Current and Future Players
出版日: 2014年06月20日 ページ情報: 英文 79 Pages
概要

脊椎固定手術は1900年代初期以降実施されている十分に確立された処置法です。米国では最も頻繁に実施される手術のひとつであり、米国市場は同分野の最大市場となっています。世界的な高齢化とそれに伴う脊椎変性疾患の発症率上昇などにより、脊椎固定市場は今後も安定した成長をみせると予測されています。

当レポートでは、脊椎固定市場における主要企業をとりあげ、地域別の競合情勢を中心に、新規参入企業、開発中のパイプライン製品、企業のプロファイルなどをまとめ、お届けいたします。

第1章 目次

第2章 イントロダクション

第3章 競合評価

  • 適応
  • 装置の種類
    • 脊椎プレーティングシステム
    • 体間ケージ
    • 椎弓根スクリューシステム
  • 企業の市場シェア
    • 米国
    • EU主要5ヶ国
    • アジア太平洋地域
    • 南米

第4章 パイプライン評価

第5章 現在および将来の主要企業

  • 概要
  • 企業戦略動向
  • 企業プロファイル
    • Aesculap
    • Alphatec Spine
    • Amedica Corporation
    • Medtronic Spinal and Biologics
    • DePuy Spine
    • Globus Medical
    • K2M
    • Biomet
    • Stryker
    • Zimmer
    • Nuvasive
    • Orthofix
    • Integra LifeSciences

第6章 付録

図表

目次
Product Code: GDME1027FPR

Spinal fusion surgery is a well-established procedure that has been performed since the early 1900s. The procedure has benefited immensely from its long history of use, investments in advancing technologies, and its clinical success in a growing variety of spinal conditions. These traits have led spinal fusion surgery to become one of the most frequently performed surgeries in the US, which is undoubtedly, the largest geographic market for this procedure. Given the global phenomenon of an aging society and the associated increasing incidences of degenerative spinal conditions, the spinal fusion market is expected to remain strong over the forecast period.

The report identifies and analyzes the key companies shaping and driving the Spinal fusion market. The report provides insight into the competitive Spinal fusion landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading doctors, with in-house analysis conducted by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Spinal fusion
  • Competitor assessment including device approval analysis.
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Spinal fusion in clinical practice.

Reasons to buy

  • Gain a high level view of the trends shaping and driving the Spinal fusion market.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Overview
  • 2.2. Catalyst

3. Competitive Assessment

  • 3.1. Indications
  • 3.2. Classification Based on System
    • 3.2.1. Spinal Plating Systems
    • 3.2.2. Interbody Cages
    • 3.2.3. Pedicle Screw Systems
  • 3.3. Company Market Share
    • 3.3.1. US
    • 3.3.2. 5EU
    • 3.3.3. APAC
    • 3.3.4. South America

4. Pipeline Assessment

5. Current and Future Players

  • 5.1. Overview
  • 5.2. Trends in Corporate Strategy
  • 5.3. Company Profiles
    • 5.3.1. Aesculap
    • 5.3.2. Alphatec Spine
    • 5.3.3. Amedica Corporation
    • 5.3.4. Medtronic Spinal and Biologics
    • 5.3.5. DePuy Spine
    • 5.3.6. Globus Medical
    • 5.3.7. K2M
    • 5.3.8. Biomet
    • 5.3.9. Stryker
    • 5.3.10. Zimmer
    • 5.3.11. Nuvasive
    • 5.3.12. Orthofix
    • 5.3.13. Integra LifeSciences

6. Appendix

  • 6.1. Bibliography
  • 6.2. Abbreviations
  • 6.3. Report Methodology
    • 6.3.1. Overview
    • 6.3.2. Coverage
    • 6.3.3. Primary Research
    • 6.3.4. Secondary Research
    • 6.3.5. Forecasting Methodology
  • 6.4. Key Opinion Leaders Included in this Study
  • 6.5. About the Authors
    • 6.5.1. Joseph A. Gregory, Analyst, Surgical Devices
    • 6.5.2. Derek Archila, MBA, Director of Research and Analysis, Medical Devices
  • 6.6. Global Head of Healthcare
    • 6.6.1. Bonnie Bain, Ph.D., Global Head of Healthcare
  • 6.7. About MediPoint
  • 6.8. About GlobalData
  • 6.9. Disclaimer

List of Tables

  • Table 1: Indications for Lumbar Spinal Fusion
  • Table 2: Spinal Surgery, US Company Market Share, 2012
  • Table 3: Spinal Surgery, 5EU Company Market Share, 2012
  • Table 4: Spinal Surgery, APAC Company Market Share, 2012
  • Table 5: Spinal Surgery, South American Company Market Share, 2012
  • Table 6: Company Portfolio - Aesculap
  • Table 7: Product Portfolio - Aesculap
  • Table 8: Company Portfolio - Alphatec Spine
  • Table 9: Product Portfolio - Alphatec Spine
  • Table 10: Company Portfolio - Amedica
  • Table 11: Product Portfolio - Amedica
  • Table 12: Company Portfolio - Medtronic Spinal and Biologics
  • Table 13: Product Portfolio - Medtronic Spinal and Biologics
  • Table 14: Company Portfolio - DePuy Spine
  • Table 15: Product Portfolio - DePuy Spine
  • Table 16: Company Portfolio - Globus Medical
  • Table 17: Product Portfolio - Globus Medical
  • Table 18: Company Portfolio - K2M
  • Table 19: Product Portfolio - K2M
  • Table 20: Company Portfolio - Biomet
  • Table 21: Product Portfolio - Biomet
  • Table 22: Company Portfolio - Stryker
  • Table 23: Product Portfolio - Stryker
  • Table 24: Company Portfolio - Zimmer
  • Table 25: Product Portfolio - Zimmer
  • Table 26: Company Portfolio - Nuvasive
  • Table 27: Product Portfolio - Nuvasive
  • Table 28: Company Portfolio - Orthofix
  • Table 29: Product Portfolio - Orthofix
  • Table 30: Company Portfolio - Integra LifeSciences
  • Table 31: Product Portfolio - Integra LifeSciences

List of Figures

  • Figure 1: Spinal Surgery, US Company Market Share, 2012
  • Figure 2: Spinal Surgery, 5EU Company Market Share, 2012
  • Figure 3: Spinal Surgery, APAC Company Market Share, 2012
  • Figure 4: Spinal Surgery, South American Company Market Share, 2012
Back to Top